GeoVax Labs, Inc. (GOVX) - Wutah bathi ing taun lumaku

GeoVax Labs, Inc. (GOVX) is developing innovative methods to combat cancer and viruses, protecting its developments through patents and lobbying. The company's revenue is based on the commercialization of genetic drug delivery platforms. However, reliance on government subsidies and the risks of clinical failures create pressure. The net income per share growth rate compared to last year confirms these trends, where the mark 76.40 records this indicator.
Rincian metrik keuangan lan pasar GeoVax Corp (GOVX)

This indicator determines the dynamics of net income per share, serving as a key measure of the business's financial productivity. By analyzing the year-over-year shift in EPS figures, an investor assesses the actual speed of asset capitalization. The metric is calculated as the percentage deviation of current earnings from the same period last year. For GeoVax Labs, Inc. (GOVX), this parameter reflects the cost efficiency of MVA vaccine development. Growth in this indicator confirms a successful transition from genetic engineering to commercial sustainability.